9 ฐานเรียนรู้
ความรู้ที่น่าสนใจ (Documents on web)
ติดต่อเรา
มูลนิธิกสิกรรมธรรมชาติ
เลขที่ ๑๑๔ ซอย บี ๑๒ หมู่บ้านสัมมากร สะพานสูง กรุงเทพฯ ๑๐๒๔๐
สำนักงาน ๐๒-๗๒๙๔๔๕๖ (แผนที่)
ศูนย์กสิกรรมธรรมชาติ มาบเอื้อง 038-198643 (แผนที่)
User login
ลิงค์เครือข่าย
law firm Dominican Republic
-
The Workplace Of Sworn Advocate Egīls Radziņš
Submitted by mitchellmcguigan56 on September 22, 2022 - 08:45Sri Lanka would seek the services of a global legislation firm, on a long run basis, to help it in its dealings with the International Monetary Fund , Cabinet spokesman, Minister Ramesh Pathirana mentioned Turkish Law Firm on Tuesday at the post-Cabinet press convention. Also I would like to mention Nirusha Ratnatunga who has delivered wonderful support services‘. Our specialist staff of immigration solicitors & legal professionals can offer you skilled immigration advice and legal representations remotely in Sri Lanka.
-
The Most Effective Legislation Firms And Attorneys In Moldova, Jap Europe, Europe
Submitted by lorenlamilami9649 on September 15, 2022 - 06:35If an individual believes they've been injured due to another's negligence they'll seek the authorized providers of a personal harm attorney to symbolize them within the legal means of submitting a declare and getting honest compensation. In the adversarial system of justice, a lawyer has an obligation to be a zealous and constant advocate on behalf of the client, and in addition has a duty to not bill the client excessively. Also, as an officer of the court, a lawyer has an obligation to be sincere and to not file frivolous circumstances or raise frivolous defenses.
-
Finest Grenada Felony Defense Attorneys & Law Companies
Submitted by avastover34933578773 on September 10, 2022 - 04:06In May 2021, TG Therapeutics submitted a supplemental New Drug Application ("sNDA") for Umbralisib to add a sign for CLL and small lymphocytic lymphoma ("SLL") in combination with Ublituximab (the "U2 sNDA"). And in September 2021, TG Therapeutics submitted a BLA to the FDA for Ublituximab as a treatment for patients with relapsing types of multiple sclerosis ("RMS") (the "Ublituximab RMS BLA"). Court proceedings are generally very long, and a trial can easily last more than twelve months.